ArticleMaterials today. Bio2026
Multifunctional biofunctionalized hybrid nanoantifungals with novel active coating agents based on cinnamaldehyde- and β-cyclocitral-modified polydopamine.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal pathogens pose serious threats to global agriculture, causing substantial crop loss and food security concerns. Current solutions often rely on conventional pesticides, generating negative environmental impacts. This study presents the development of two novel multifunctional hybrid nanoparticles designed to provide a sustainable alternative for crop protection and growth promotion. These nanoparticles are based on dendritic mesoporous silica nanoparticles (dMSNs) and functionalized with innovative coating agents derived from cinnamaldehyde- (CIN) and β-cyclocitral (βETA) -modified polydopamine (DOPA). The purpose of this research was to create a system that could deliver antifungal agents and support plant development simultaneously, especially under pathogen-induced stress. Nanoparticles exhibited a dual-release mechanism with pH-responsive kinetics, releasing up to 94 % of geraniol (GER) and 81 % of compound βETA, at pH 5. This confirms their ability for targeted, stimulus-triggered delivery. In vitro tests showed strong antifungal activity against several plant pathogenic fungi, with minimum inhibitory concentrations down to 0.078 mg/mL. Microscopic analysis revealed significant disruption of fungal mycelia after treatment, confirming the antifungal mechanism. In vivo biosafety was established through assays on
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.